Clinical Updates
Drug approvals, guideline changes, and treatment advances
MHRA Approves First Needle-Free Adrenaline Nasal Spray for Young Children
UK regulators approve the first needle-free adrenaline nasal spray for children as young as 12 months, offering a breakthrough treatment…
Editor's Top Picks
Pfizer’s Monthly Obesity Drug Shows Promise in Detailed Midstage Trial Data
Detailed midstage trial data provide further evidence that Pfizer's obesity drug berobenatide, acquired from Metsera, could offer effective weight management…
Submit Your Paper →
More form Clinical Updates
Strong nurse-patient relationships reduce psychiatric hospital stays, UK study finds
New research shows that strong therapeutic relationships between psychiatric nurses and patients, formed within the…
Teclistamab Shows Strong Response Rates in Earlier-Line Multiple Myeloma Treatment
Phase 3 trial shows teclistamab extends progression-free survival by 7.3 months compared with standard treatments…
Revolution Medicines Ships Experimental Pancreatic Cancer Drug Under Early Access
Revolution Medicines begins expanded access program for daraxonrasib targeting KRAS G12C mutations. FDA submission planned…
DNA Test Could Spare 6,600 Breast Cancer Patients From Unnecessary Chemotherapy
New genetic testing could spare 6,600 UK breast cancer patients annually from unnecessary chemotherapy while…
New Blood Tests and Stool Screens Join Colonoscopy as Primary Options for Colorectal Cancer Detection
The American Cancer Society updated colorectal cancer screening guidelines to include blood-based tests alongside colonoscopy…